OTC Markets EXMKT - Delayed Quote USD

SK3 Group, Inc. (SKTO)

0.0000
0.0000
(0.00%)
At close: May 27 at 4:00:00 PM EDT
Loading Chart for SKTO
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0000
  • Volume 27,500
  • Avg. Volume 16
  • Market Cap (intraday) 1.522M
  • Beta (5Y Monthly) -1.87
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

SK3 Group, Inc. provides management advisory, licensing, and marketing services for medical marijuana collectives in California. It licenses various products for marketing and sale, including the YAK line of medical marijuana edibles; Canna-Loz, a delivery system for large doses of phyto-cannabinoids; Yeti, a pre-roll for pain relief; and Dharmanol, a proprietary technology that extracts, stabilizes, and preserves the medicinal cannabinoids found in hemp and marijuana in their non-psychoactive form. The company was formerly known as CTT International Distributors, Inc. and changed its name to SK3 Group, Inc. in May 2007. The company was founded in 2000 and is headquartered in Los Angeles, California. SK3 Group, Inc. is a subsidiary of Healthcare of Today, Inc.

15

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SKTO

View More

Performance Overview: SKTO

Trailing total returns as of 5/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SKTO
100.00%
S&P 500 (^GSPC)
0.12%

1-Year Return

SKTO
100.00%
S&P 500 (^GSPC)
10.98%

3-Year Return

SKTO
100.00%
S&P 500 (^GSPC)
41.61%

5-Year Return

SKTO
80.00%
S&P 500 (^GSPC)
94.36%

Compare To: SKTO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SKTO

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.28%

  • Return on Assets (ttm)

    4.52%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    7.95M

  • Net Income Avi to Common (ttm)

    22.2k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    284

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -42.13k

Research Analysis: SKTO

View More

Company Insights: SKTO

Research Reports: SKTO

View More

People Also Watch